Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis - Biognosys

Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis

Posters

Poster presented at ESMO 2022

 
Authors: Domenico Mallardo, Christoph Messner, Mariaelena Capone, Jakob Vowinckel, Antonio Sorrentino, Karel Novy, Vito Vanella, Kristina Beeler, Sarah Warren, Paolo Ascierto
Presenter: Domenico Mallardo (Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy)

Date: September 10

Back to Resources overview

Contact

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More